Fyarro Injection, Powder, Lyophilized, For Suspension
Product Images NDC 80803-153

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fyarro (NDC 80803-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aadi Bioscience, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Carton)

Principal Display Panel (Carton)
The text describes a prescription drug with NDC code 80803-153-50, named Fyarro. It contains sirolimus protein-bound particles in an injectable suspension with 100 mg per vial. It is intended for intravenous infusion and any unused portion should be discarded.*
FDA Label Image

Image Of Proper Solution Flow Onto The Inside Wall Of The Vial (Figure1)

FDA Label Image

The Structural Formula Of Sirolimus (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.